首页> 中文期刊> 《实用临床医药杂志》 >腹腔镜下前列腺癌根治术结合内分泌辅助治疗高危前列腺癌的效果

腹腔镜下前列腺癌根治术结合内分泌辅助治疗高危前列腺癌的效果

         

摘要

目的 探讨腹腔镜下前列腺癌根治术结合内分泌辅助治疗高危前列腺癌的效果.方法 选取50例局部晚期高危前列腺癌患者,均行腹腔镜下前列腺癌根治术治疗,根据术后是否进行辅助内分泌治疗(AHT)将其分为观察组及对照组,比较2组手术一般情况及2年生存率.结果 50例患者均成功手术.观察组的2年总体无生化复发率为76%,对照组为52.00%,观察组中进行AHT治疗的所有患者在随访过程中均能够耐受治疗.结论 腹腔镜下前列腺癌根治术结合内分泌辅助治疗高危前列腺癌,能够显著提高患者的2年无生化复发率,控制疾病进展.%Objective To explore the effect of laparoscopic radical prostatectomy for prostate cancer combined with endocrine adjuvant therapy on the treatment of patients with high-risk prostate cancer.Methods A total of 50 patients with local advanced high-risk prostate cancer were treated with laparoscopic radical treatment for prostate cancer.According to application of postoperative adjuvant endocrine therapy (AHT),the patients were divided into the observation group and control group.General surgery condition and 2-year survival rate were compared between two groups.Results All the 50 patients finished operation successfully.The 2-year total biochemical recurrence rate was 76% in observation group,and the control group was 52.00%.The patients received AHT therapy in the observation group were able to tolerate treatment during follow-up.Conclusion Laparoscopic radical prostatectomy for prostate cancer combined with endocrine adjuvant therapy can significantly improve 2-year non-biochemical recurrence rate and control the disease progression.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号